Authors: PANDITA TK BENVENUTO JA SHAY JW PANDITA RK RAKOVITCH E GEARD CR ANTMAN KH NEWMAN RA

Citation: Tk. Pandita et al., EFFECT OF PENCLOMEDINE (NSC-338720) ON TELOMERE FUSIONS, CHROMATIN BLEBBING, AND CELL VIABILITY WITH AND WITHOUT TELOMERASE ACTIVITY AND ABROGATED P53 FUNCTION, Biochemical pharmacology, 53(3), 1997, pp. 409-415

Authors: BENVENUTO JA HITTELMAN WN ZWELLING LA PLUNKETT W PANDITA TK FARQUHAR D NEWMAN RA

Citation: Ja. Benvenuto et al., BIOCHEMICAL PHARMACOLOGY OF PENCLOMEDINE (NSC-338720), Biochemical pharmacology, 50(8), 1995, pp. 1157-1164

Authors: NEWMAN RA FUENTES A COVEY JM BENVENUTO JA

Citation: Ra. Newman et al., PRECLINICAL PHARMACOLOGY OF THE NATURAL MARINE PRODUCT DOLASTATIN-10 (NSC-376128), Drug metabolism and disposition, 22(3), 1994, pp. 428-432

Authors: BENVENUTO JA JOHNSTON DA NISHIOKA K

Citation: Ja. Benvenuto et al., THE CORRELATION OF RESPONSE WITH PLASMA PHARMACOKINETICS AND POLYAMINE CONCENTRATIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVINGAMONAFIDE, Cancer letters, 70(3), 1993, pp. 175-179

Authors: BENVENUTO JA CONNOR TH MONTEITH DK LAIDLAW JL ADAMS SC MATNEY TS THEISS JC

Citation: Ja. Benvenuto et al., DEGRADATION AND INACTIVATION OF ANTITUMOR DRUGS, Journal of pharmaceutical sciences, 82(10), 1993, pp. 988-991